Skip to contentC
Cardio Diagnostics Holdings, Inc.
C
CDIOCardio Diagnostics Holdings, Inc. Q1 2025 · 10-Q
Revenue$940.00$940.00−94.1% vs Q1 2024 Net Income-$1.64M-$1.64MN/M vs Q1 2024 EPS Diluted-$0.97-$0.97N/M vs Q1 2024 Operating Income-$1,630,560N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cardio Diagnostics Holdings, Inc. · CIK 1870144 · Engraved from SEC EDGAR
Free Cash Flowderived-$1,405,888N/M Margins · derivedOperating margin-173463.8%−147358.6 pt vs Q1 2024
Net margin-173943.0%−147802.9 pt vs Q1 2024
ended Mar 31, 2025 · filed May 15, 2025 · 45 d after period end